{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:47:00Z","timestamp":1648882020387},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1053\/j.ackd.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T18:16:24Z","timestamp":1345745784000},"page":"287-290","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Immunological Assessment in Patients With Acute Kidney Injury and Possible Myeloma"],"prefix":"10.1053","volume":"19","author":[{"given":"Helen J.","family":"Lachmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Wassef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2012.07.002_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in\u00a0multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.ackd.2012.07.002_bib2","doi-asserted-by":"crossref","unstructured":"Stringer S, Basnayake K, Hutchison C, Cockwell P. Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney). [e-pub ahead of print]. Bone Marrow Res. doi:10.1155\/2011\/493697.","DOI":"10.1155\/2011\/493697"},{"key":"10.1053\/j.ackd.2012.07.002_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3322\/CA.57.5.301","article-title":"Multiple myeloma: charging toward a bright future","volume":"57","author":"Katzel","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.ackd.2012.07.002_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"25","author":"Raab","year":"2009","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2012.07.002_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ackd.2012.07.002_bib6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2010-03-258608","article-title":"Kidney disease associated with plasma cell dyscrasias","volume":"116","author":"Heher","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2012.07.002_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.ackd.2012.07.002_bib8","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"10.1053\/j.ackd.2012.07.002_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin Chem"},{"key":"10.1053\/j.ackd.2012.07.002_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1515\/CCLM.2009.254","article-title":"Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies","volume":"47","author":"B\u00f6er","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/j.ackd.2012.07.002_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1373\/clinchem.2005.048017","article-title":"Serum free light chain measurements move to center stage","volume":"51","author":"Bradwell","year":"2005","journal-title":"Clin Chem"},{"key":"10.1053\/j.ackd.2012.07.002_bib12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1373\/clinchem.2011.171314","article-title":"Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies","volume":"57","author":"Katzmann","year":"2011","journal-title":"Clin Chem"},{"key":"10.1053\/j.ackd.2012.07.002_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","article-title":"Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy","volume":"122","author":"Lachmann","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.ackd.2012.07.002_bib14","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2009.123828","article-title":"Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa\/lambda ratios","volume":"55","author":"Bradwell","year":"2009","journal-title":"Clin Chem"},{"key":"10.1053\/j.ackd.2012.07.002_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/MNH.0b013e32833ef72c","article-title":"Management options for cast nephropathy in multiple myeloma","volume":"19","author":"Cockwell","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.ackd.2012.07.002_bib16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/bmt.2011.8","article-title":"Renal failure in multiple myeloma: a medical emergency","volume":"46","author":"Wirk","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.ackd.2012.07.002_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2007-01-067728","article-title":"High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis","volume":"110","author":"van Rhee","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2012.07.002_bib18","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.07.002_bib19","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1182\/blood-2008-02-138602","article-title":"Appraisal of immunoglobulin free light chain as a marker of response","volume":"111","author":"Dispenzieri","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.ackd.2012.07.002_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.2010.30.5235","article-title":"Outcome in renal AL amyloidosis following chemotherapy","volume":"29","author":"Pinney","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ackd.2012.07.002_bib21","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2215\/CJN.03350411","article-title":"Serum free light chains and the risk of ESRD and death in CKD","volume":"6","author":"Haynes","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2012.07.002_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2008.07079.x","article-title":"The evolving use of serum free light chain assays in haematology","volume":"141","author":"Pratt","year":"2008","journal-title":"Haematol"},{"key":"10.1053\/j.ackd.2012.07.002_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1258\/000456307782268183","article-title":"Free light chains","volume":"44","author":"Sheldon","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1053\/j.ackd.2012.07.002_bib24","doi-asserted-by":"crossref","unstructured":"Hutchison CA, Heyne N, Airia P, et\u00a0al. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. [e-pub ahead of print]. Nephrol Dial Transplant. doi:10.1093\/ndt\/gfr773.","DOI":"10.1093\/ndt\/gfr773"},{"key":"10.1053\/j.ackd.2012.07.002_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrneph.2009.151","article-title":"Serum free light chain assessment in monoclonal gammopathy and kidney disease","volume":"5","author":"Hutchison","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ackd.2012.07.002_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2141.2007.06561.x","article-title":"Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma","volume":"137","author":"Kyrtsonis","year":"2007","journal-title":"Br J Haematol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559512001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559512001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T21:24:45Z","timestamp":1594589085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559512001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1548559512001395"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2012.07.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}